Effects of psychoactive drugs on cyclic nucleotides in the central nervous system.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D006162:Guanylate Cyclase / Q000378:metabolism; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D008094:Lithium / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011619:Psychotropic Drugs / Q000494:pharmacology*
D000927:Anticonvulsants; D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D008996:Monoamine Oxidase Inhibitors; D009294:Narcotics; D011619:Psychotropic Drugs; D008094:Lithium; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D006162:Guanylate Cyclase; D006152:Cyclic GMP